Exact UK legal entity

OXFORD BIOTHERAPEUTICS LTD

04974481 · active · No overdue accounts or confirmation flag returned

Current statusactive
Incorporated24 November 2003
Accounts due30 September 2026
Confirmation due10 June 2027
Status checked via live Companies House proxy at 15 September 2026. This is a public-record research page, not a credit score, investment conclusion or tax determination.

Identity and review status

Portfolio context

1 mapped fund association

Calculus Capital

Association means the company appeared in the dated portfolio research corpus. It does not prove a fund's current holding or SEIS/EIS eligibility.

Observed names

Identity and alias evidence

Names are not merged by similarity. Every non-current label below is tied to this exact company number or to the exact GLEIF identifier join, and its role is stated.

Name as publishedEvidence typeObservation or match
OXFORD BIOTHERAPEUTICS LTDCurrent registered nameCompanies House number 04974481
OXFORD BIO THERAPEUTICS LTDPrevious registered nameEffective 26 November 2008 · ceased 16 March 2009
OXFORD GENOME SCIENCES (UK) LIMITEDPrevious registered nameEffective 19 December 2003 · ceased 26 November 2008
GW 1155 LIMITEDPrevious registered nameEffective 24 November 2003 · ceased 19 December 2003
Oxford BiotherapeuticsPortfolio snapshot labelObserved in the curated corpus imported 15 August 2026
Exact links only

Company relationship map

This graph shows exact company-number and legal-identifier links. It does not infer beneficial ownership, control or group structure from names.
CompanyOXFORD BIOTHERAPEUTICS LTD04974481
Mapped portfolios1

Calculus Capital

Observed in the 15 August 2026 research snapshot
Observed facts

Cross-source evidence timeline

Dated company filings, public-contract notices and identifier events are sorted together. This is chronology, not a claim that one event caused another.

  1. Confirmation Statement made up to 27 May 2026Companies House filing · CS01 · Confirmation Statement
  2. Persons With Significant Control dated 24 March 2026Companies House filing · PSC05 · Persons With Significant Control
  3. CapitalCompanies House filing · SH01 · Capital
  4. Accounts made up to 31 December 2024Companies House filing · AA · Accounts
  5. Confirmation Statement made up to 27 May 2025Companies House filing · CS01 · Confirmation Statement
  6. CapitalCompanies House filing · SH01 · Capital
  7. Accounts made up to 31 December 2023Companies House filing · AA · Accounts
  8. CapitalCompanies House filing · SH01 · Capital
  9. ResolutionCompanies House filing · RESOLUTIONS · Resolution
  10. Confirmation Statement made up to 27 May 2024Companies House filing · CS01 · Confirmation Statement
  11. CapitalCompanies House filing · SH01 · Capital
  12. Accounts made up to 31 December 2022Companies House filing · AA · Accounts
  13. Address dated 31 August 2023Companies House filing · AD01 · Address
  14. OfficersCompanies House filing · TM01 · Officers
  15. Confirmation Statement made up to 27 May 2023Companies House filing · CS01 · Confirmation Statement
  16. CapitalCompanies House filing · SH01 · Capital
  17. Registered name ceased: OXFORD BIO THERAPEUTICS LTDCompanies House · Previous-name record
  18. Registered name became OXFORD BIO THERAPEUTICS LTDCompanies House · Previous-name record
  19. Registered name ceased: OXFORD GENOME SCIENCES (UK) LIMITEDCompanies House · Previous-name record
  20. Registered name became OXFORD GENOME SCIENCES (UK) LIMITEDCompanies House · Previous-name record
  21. Registered name ceased: GW 1155 LIMITEDCompanies House · Previous-name record
  22. Company incorporatedCompanies House · Registered as OXFORD BIOTHERAPEUTICS LTD
  23. Registered name became GW 1155 LIMITEDCompanies House · Previous-name record
Companies House

Filing timeline

Open complete official history →

Recent events are shown newest first. Filing codes and dates come directly from Companies House; descriptions are concise labels, not legal interpretations.

  1. Confirmation Statement made up to 27 May 2026CS01 · Confirmation Statement
  2. Persons With Significant Control dated 24 March 2026PSC05 · Persons With Significant Control
  3. CapitalSH01 · Capital
  4. Accounts made up to 31 December 2024AA · Accounts
  5. Confirmation Statement made up to 27 May 2025CS01 · Confirmation Statement
  6. CapitalSH01 · Capital
  7. Accounts made up to 31 December 2023AA · Accounts
  8. CapitalSH01 · Capital
  9. ResolutionRESOLUTIONS · Resolution
  10. Confirmation Statement made up to 27 May 2024CS01 · Confirmation Statement
  11. CapitalSH01 · Capital
  12. Accounts made up to 31 December 2022AA · Accounts
  13. Address dated 31 August 2023AD01 · Address
  14. OfficersTM01 · Officers
  15. Confirmation Statement made up to 27 May 2023CS01 · Confirmation Statement
  16. CapitalSH01 · Capital

Ownership and governance sources

CompanyBeacon does not republish raw officer, PSC, address or date-of-birth records. For ownership or governance diligence, review the current official registers and record the source date separately from any conclusion.
Official control register

People with significant control

PSC entries describe published legal control and are not necessarily a complete economic ownership graph.

Review the official PSC register →
Official governance register

Company officers

Appointment records are governance evidence, not proof of beneficial ownership, conduct or current decision-making authority.

Review the official officer list →

Source dates and limitations

  • charity-commission-register: extract Not available, imported 25 July 2026.
  • companies-house-relevant-subset: extract Not available, imported 25 July 2026.
  • contracts-finder-daily-csv: extract 14 September 2026, imported 15 September 2026.
  • Live company status and filing metadata can change after this page is cached. Companies House remains authoritative.
  • Raw officer, PSC, address and date-of-birth records are not republished.
  • SEIS/EIS qualification, investment performance, creditworthiness and beneficial ownership are not inferred.

Use the due-diligence checklist or review the methodology.